Antipsychotic Use Trends in Youth With Autism Spectrum Disorder and/or Intellectual Disability: A Meta-Analysis

作者：Park Su Young; Cervesi Chiara; Galling Britta; Molteni Silvia; Walyzada Frozan; Ameis Stephanie H; Gerhard Tobias; Olfson Mark; Correll Christoph U^*

来源：Journal of the American Academy of Child and Adolescent Psychiatry, 2016, 55(6): 456-468.

DOI：10.1016/j.jaac.2016.03.012

• antipsychotic
• child
• adolescent
• autism
• intellectual disability

Objective: Although irritability and aggression are relevant treatment targets in autism spectrum disorders (ASDs) and intellectual disability (ID) that may prompt antipsychotic use, antipsychotic prescribing patterns in such youth have not been systematically reviewed.
Method: We systematically searched PubMed/MEDLINE/PsycInfo until March 2015 for studies reporting data on the frequency of youth diagnosed with ASDs and/or ID among antipsychotic-treated youth, as well as antipsychotic use in youth with ASD/ID, conducting a meta-analysis and meta-regression analysis of potential moderators, including publication year, study time point, country, setting, sample size, age, sex, and race/ethnicity.
Results: A total of 39 studies were meta-analyzed (n = 365,449, age = 11.4 +/- 6.2 years, males = 70.0%+/- 10.0%). Among 27 studies (n = 273,139, age = 11.9 +/- 8.0 years, males = 67.0%+/- 12.9%) reporting on antipsychotictreated youth, 9.5% (95% CI = 7.8%-11.5%) were diagnosed with ASD/ID. In 20 studies (n = 209,756) reporting data separately for ASD, 7.9% (95% CI = 6.2%-9.9%) had an ASD diagnosis. In 5 longitudinal studies, the proportion of antipsychotic-treated youth with ASD did not change significantly from 1996 to 2011 (6.7% to 5.8%, odds ratio = 0.9, 95% CI = 0.8-1.0, p =.17). However, later study time point moderated greater ASD/ID proportions (beta = 0.12, p <.00001). In 13 studies (n = 96,688, age = 9.8 +/- 1.2 years, males = 78.6%+/- 2.0%) reporting on antipsychotic use in ASD samples, 17.5% (95% CI = 13.7%-22.1%) received antipsychotics. Again, later study time point moderated higher antipsychotic use among patients with ASD (beta = 0.10, p =.004).
Conclusion: Almost 1 in 10 antipsychotic-treated youth were diagnosed with ASD and/or ID, and 1 in 6 youth with ASD received antipsychotics. Both proportions increased in later years; however, clinical reasons and outcomes of antipsychotic use in ASD/ID require further study.

• 出版日期2016-6
• 单位河北医科大学